The largest database of trusted experimental protocols

9 protocols using anti hla dr clone l243

1

Profiling HLA-DR Peptidome from mo-DCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antigen-pulsed mo-DCs were collected and washed with cold buffer A (PBS, 2 mM EDTA; pH 7.4–7.6). The cells were then lysed in cold buffer B (1% CHAPS, 1 mM EDTA, protease inhibitor cocktail) and incubated at 4° C on a rocking table for 15 minutes. This lysis step was repeated, insoluble material removed by centrifugation, and the supernatant was incubated with Protein G Dynabeads (Thermo Fisher) coated with 20 ug of anti-HLA-DR (clone L243, BioLegend) or isotype control (clone MOPC-173, BioLegend) antibodies at 4° C for one hour with inversion. The beads were then washed 4-times with lysis buffer B, and 3-times with buffer C (20 mM Tris, 150 mM NaCl, pH 7.4). The HLA-DR-bound peptides were eluted by incubating the beads with 0.1% TFA for 1 minute at room temperature and harvesting the eluate. This step was repeated once and the pooled eluate was centrifuged through a 10kD centrifugal filter (Microcon, Millipore). The filter was washed with 0.1 % TFA and pooled flow-through containing the eluted peptides was lyophilized by vacuum centrifugation. The peptides were then analyzed by mass spectrometry, as described in detail in the online supplementary material and methods.
+ Open protocol
+ Expand
2

Surface Marker Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface marker expression was determined by flow cytometry using anti-HLA-DR (clone L243; Biolegend, San Diego, CA), anti-TNFR-1 (clone 16803), anti-TNFR-2 (clone 22235), and anti-TACE (clone 111633, all R&D Systems) antibodies in conjunction with the manufacturer recommended isotype control. Cells were incubated with fluorophore-conjugated anti-human antibodies for 30 minutes at 4°C. A Cyan ADP fluorescence-activated cell sorter (Beckman Coulter, High Wycombe, United Kingdom) using Summit version 4.3.02 (Beckman Coulter) was used for acquisition and Flowjo V.7.5 (Tree Star, Ashland, OR) for analysis. Expression levels are reported as the geometric mean of the fluorescence intensity (MFI).
+ Open protocol
+ Expand
3

Whole Blood Flow Cytometry Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
A whole blood flow cytometry technique was employed as previously described [47 (link)]. Whole-blood samples (200ul) were stained at room temperature for 20 minutes. The following directly conjugated monoclonal antibodies (mAbs) were used: anti-CD3 (clone UCHT1, BD Biosciences), anti-CD4 (clone L-200, BD Biosciences), anti-CD8 (clone SK1, BD Biosciences), anti-CD27 (clone L128, BD Biosciences), anti-CD38 (clone LS-198, Beckman Coulter), anti-CD45RA (clone AbB11, Beckman Coulter) and anti-HLA-DR (clone L243, Biolegend). Red cells were lysed and fixed in FACS lysing solution (BD Biosciences) for 10 minutes in the dark, washed twice in FACS buffer (phosphate-buffered saline (PBS) containing 2% bovine serum albumin and 0.1% NaN3), and fixed with 1% formalin in PBS. Cells were acquired on an LSR-II flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
4

Quantifying Surface HLA-DR and BAFF-R in EBV Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine surface expression of the class II antigen HLA-DR and the BAFF receptor (BAFF-R) in the different EBV-transformed cell lines, cells were suspended in MACS buffer (PBS containing 0.5 % [w/v] bovine serum albumin and 2 mM EDTA, pH 7.4) and stained for 30 min at 4°C with anti-HLA-DR (clone L243, BioLegend) or anti-BAFF-R (CD268, clone 11C1, BioLegend) conjugated to APC and PE, respectively. For detection of total HLA-DR, cells were fixed and permeabilized with Cytofix/Cytoperm™ Solution (BD Biosciences) for 20 min at 4°C and washed twice with Perm/Wash™ (BD Biosciences) prior to staining with anti- HLA-DR for 30 min at 4°C. Flow cytometry was performed using a FACSCanto flow cytometer (BD) and data were analysed using FlowJo (Tree Star) software.
+ Open protocol
+ Expand
5

Whole Blood Flow Cytometry Method

Check if the same lab product or an alternative is used in the 5 most similar protocols
A whole blood flow cytometry technique was employed as previously
described [47 (link)]. Whole-blood samples
(200ul) were stained at room temperature for 20 minutes. The following directly
conjugated monoclonal antibodies (mAbs) were used: anti-CD3 (clone UCHT1, BD
Biosciences), anti-CD4 (clone L-200, BD Biosciences), anti-CD8 (clone SK1, BD
Biosciences), anti-CD27 (clone L128, BD Biosciences), anti-CD38 (clone LS-198,
Beckman Coulter), anti-CD45RA (clone AbB11, Beckman Coulter) and anti-HLA-DR
(clone L243, Biolegend). Red cells were lysed and fixed in FACS lysing solution
(BD Biosciences) for 10 minutes in the dark, washed twice in FACS buffer
(phosphate-buffered saline (PBS) containing 2% bovine serum albumin and
0.1% NaN3), and fixed with 1% formalin in PBS. Cells
were acquired on an LSR-II flow cytometer (BD Biosciences).
+ Open protocol
+ Expand
6

Flow Cytometric Analysis of Dendritic Cell Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell-surface phenotypes of unstimulated and stimulated DCs were analysed by flow cytometry using human-specific mAbs: anti-CD40 (clone 5C3) and anti-CD83 (clone HB15e) (eBioscience); anti-CD80 (clone L307.4), anti-CD86 (clone IT2.2) and anti-CD11c (clone B-ly6) (BD); anti-HLA-A,B,C (clone W6/32) and anti-HLA-DR (clone L243) (BioLegend), together with the respective isotype controls. Optimal concentrations of the antibodies were determined prior to flow cytometry assays. The DC population was selected by gating on cells that were double positive for CD11c and MHC-II. Median fluorescence intensity (MFI) was used as measure for expression of the analysed molecules. Data was acquired using Canto II flow cytometer (BD) and analysed using FlowJo software.
+ Open protocol
+ Expand
7

Monocyte Immunophenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Elutriated monocytes or MACS-purified CD16+ and CD16neg monocytes were stained with the following antibodies: anti-CD14 (clone M0Pg, BD Biosciences, San Jose, CA), anti-CD16 (clone 3G8, Biolegend, San Diego, CA), anti-HLA-DR (clone L243, Biolegend), anti-CD119 (clone GIR-208, Thermo Fisher Scientific, , Gaithersburg, MD) or anti-IFNγR2-APC (clone C38, Creative Diagnostic, Shirley, NY) and sorted or analyzed using a FACS Aria or FACS Symphony (BD Biosciences), respectively.
+ Open protocol
+ Expand
8

Comprehensive Multicolor Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were analyzed by flow cytometry using the following anti-human antibodies: anti-CD14 (clone M5E2; BioLegend, London, UK), anti-CD86 (clone IT2.2; BioLegend), anti-CD83 (clone HB15e, BD Bioscience, Oxford, UK), anti-CD11c (clone 3.9; BioLegend), anti-CD1c (clone L161; BioLegend), anti-HLA-DR (clone, L243; BioLegend), anti-CD13 (clone WM15; BioLegend), anti-CD33 (clone P67.6; BioLegend), anti-CD141 (clone 1A4; BD Bioscience, Oxford, UK), and anti-CD11b (clone ICRF44; eBioscience). Dead cells were identified using fixable Viability dye Zombie UV (BioLegend, UK). The data were acquired on a LSRII flow cytometer or Fortessa (BD Bioscience) and analyzed using FACSDiva (BD Bioscience) or FlowJo software (Tree Star, Ashland, Oregon).
+ Open protocol
+ Expand
9

IFN-γ Secretion ELISpot Assay for HLA Restriction

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine HLA restriction, IFN-γ secretion was measured in ELISpot assays in the presence or absence of blocking antibodies. 10 µg/mL of anti-HLA-A,B,C (clone w6/32, Biolegend), anti-HLA-DQ (clone 1A3, Leinco) and/or anti-HLA-DR (clone L243, Biolegend) antibodies were added to 5T4-expanded T cells in ELISpot assays. 5T4 peptides were added following 1 h incubation with blocking antibodies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!